Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2023-07-20 | 2023-10-04 | 199387 |
| TEVA-TOLTERODINE | 1MG | TABLET | Actual shortage | 2023-10-05 | 2024-01-08 | 206410 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Actual shortage | 2024-01-11 | 2024-05-03 | 215707 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2024-03-21 | 2024-03-21 | 222947 |
| TEVA-AMPHETAMINE XR | 2.5MG 2.5MG 2.5MG 2.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-30 | 2019-01-31 | 68265 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | TABLET | Resolved | 2024-01-11 | 2024-01-19 | 215757 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2017-03-13 | 2018-03-14 | 1137 |
| TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-13 | 2020-02-13 | 1674 |
| ACT AMLODIPINE | 2.5MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3348 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2017-04-03 | 2018-02-21 | 5213 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-05-10 | 2018-01-03 | 9802 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-08-02 | 2018-01-03 | 17987 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19968 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86884 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-01-30 | 2020-03-19 | 104905 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2020-02-07 | 2021-04-01 | 105590 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107955 |
| TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-04-10 | 2020-05-14 | 111807 |
| TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113019 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2020-07-23 | 2020-09-17 | 120884 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |